Providers/Grant Support
This activity is sponsored by the California Academy of Family Physicians and funded by the California Department of Public Health. The contents may not necessarily reflect the official views or policies of the State of California.
Credits Available
- Family Physicians — maximum of 1.0 AAFP Prescribed credit
- AMA Credit – AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1.
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is designed to meet the educational needs of Primary Care Providers, including physicians, nurse practitioners physician associates, and also pharmacists.
Program Overview
Reproductive health, including abortion care, is an important element of primary care practice. The current environment in the US has created fear and anxiety for patients and their care providers, prompted by uncertainty about availability and legality of services. Education and training that expand access to abortion care in primary care settings can help to alleviate some of the barriers to care that patients currently face.
Meet a diverse collection of patients, similar to those who you may encounter in your practice. Expand and apply your skills and knowledge related to medication abortion, both in the exam room and through telehealth.
Four cases focus on key considerations that impact the decision to prescribe medication for abortion, and how to manage common questions, concerns or complications that may arise.
These cases were developed by California Academy of Family Physicians’ Reproductive Health Faculty Advisory Panel and highlight real-world scenarios faced by family physicians who choose to integrate medication abortion care into their practice. To learn more about the other CME activities CAFP has developed, or CAFP’s Reproductive Health Initiative, go to familydocs.org/rhi.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Evaluate common considerations and contraindications for safely prescribing mifepristone and misoprostol.
- Identify unique considerations for managing medication abortions via telehealth as compared to in an in-person healthcare setting.
- Apply effective decision-making strategies to triage concerns or complications that can arise during the management of medication abortions.
- Demonstrate person-centered communication strategies in the provision of medication abortion.
Faculty
Sheila Attaie, DO
Dr. Sheila Attaie (she/her) is an Iranian-American family physician from the Sacramento area. She is an assistant clinical professor in the Department of Family and Community Medicine at University of California, Davis. She is also a contract provider with Lilith Clinic and Planned Parenthood Great Plains, as well as a volunteer for the M+A hotline. Her interests in medicine include abortion liberation, refugee and immigrant health, and mental health. Outside of medicine, she fills her cup with hiking, snowboarding, dancing, DJing, and international travel!
Disclosure: Dr. Attaie has no relevant financial relationships with ineligible companies to disclose.
Shannon Connolly, MD, FAAFP
Dr Shannon Connolly (she/her) completed medical school at the University of Southern California and residency in family medicine at UCLA. She is a former Associate Medical Director at Planned Parenthood of Orange and San Bernardino Counties, and founder of Open Arms Primary Care, a Direct Primary Care practice focused on providing inclusive care to populations who have been overlooked by the traditional healthcare system. She has served as president of the California Academy of Family Physicians and is currently Chair of the Committee on Justice through Equity, Diversity, and Inclusion for the CAFP. Additionally, she sits on the Commission for Diversity, Equity, and Inclusion in Family Medicine for the American Academy of Family Physicians. Her clinical interests include abortion and family planning, gender affirming care, and health equity.
Disclosure: Dr. Connolly has no relevant financial relationship(s) with ineligible companies to disclose.
C. Peony Khoo, MD, FAAFP
Dr. Khoo (she/her) is a family physician in downtown Los Angeles. She serves as the Associate Program Director at the California Hospital Medical Center Family Medicine Residency Program where she provides full-spectrum family medicine care, including surgical obstetrics. She is also a Supervising Physician at Planned Parenthood Pasadena and San Gabriel Valley. She serves in leadership positions in family medicine in local, state, and national committees. Her clinical interests include reproductive health, obstetrics, addiction medicine, and lactation/breastfeeding medicine.
Disclosure: Dr. Khoo has no relevant financial relationships with ineligible companies to disclose.
Amy Tressan, MD
Dr. Tressan (she/her) completed medical school at Thomas Jefferson Medical College in Philadelphia and residency in family medicine at UCLA. She then completed her medical training with a family planning fellowship with the Reproductive Health Access Project in Boston and a subsequent fellowship (LTA) with Physicians for Reproductive Health. Beginning in 2026 she is the Director of gynecology and reproductive health services at the LA LGBT Center, where she practices comprehensive primary care. Her areas of clinical interest include diversity and equity within healthcare delivery, trauma informed care, abortion access, and gender affirming care. Outside of work, Dr. Tressan is involved in several professional organizations which focus on advocacy for access to family planning services.
Disclosure: Dr. Tressan has no relevant financial relationships with ineligible companies to disclose.
Aisha Wagner, MD
Dr. Wagner completed medical school at the Keck School of Medicine and residency at University of California, San Francisco. She then went on to do a fellowship in Reproductive Health and Advocacy in New York through the Reproductive Health Access Project, as well as a fellowship with Physicians for Reproductive Health. Dr. Wagner currently works providing primary care at an FQHC, as a contract provider for Planned Parenthood Los Angeles, fellowship director for TEACH (Training in Early Abortion for Comprehensive Healthcare), and recently as the co-Chief Medical Officer for Choix Health, a telehealth platform offering MAB.
She has created and collaborated on reproductive health, reproductive rights, and reproductive justice advocacy projects, taught women’s health procedures (including abortion) to medical students, residents, nurse practitioners, and other medical professionals. She has also spoken as an expert on contraception and abortion care with media, state representatives, on panels, and as an invited Grand Rounds speaker. In her free time (which is very limited these days) she enjoys buying ridiculous numbers of plants.
Disclosure: Dr. Wagner has no relevant financial relationships with ineligible companies to disclose.
Accreditation Statement
California Academy of Family Physicians is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
The AAFP has reviewed the enduring activity, Shared Decisions, Safe Choices: Complex Cases in Medication Abortion, and deemed it acceptable for up to 1.00 AAFP Prescribed credit. Term of Approval is from 10/01/2025 to 9/30/2026. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1.
Disclosures of Conflict of Interest
California Academy of Family Physicians’ Committee on Continuing Professional Development and CME will be responsible for mitigating any relevant financial relationships disclosed by an individual who may have influence on content, who have served as faculty, or who may produce CME/CPD content for the CAFP. Mitigation may include learner notification, peer review of content before presentation, requirement of EB-CME, changing topics, or even dismissing a potential faculty member.
It is the policy of the CAFP to ensure independence, balance, objectivity, scientific rigor, and integrity in all continuing education activities. All individuals with potential to influence the content of this program have submitted Disclosure of Interest declarations that have been reviewed according to policy. Learner notification of declarations is below. All individuals with relevant financial relationships with ineligible companies have been contacted by CAFP staff or CCPD members, and issues of conflict have been discussed and mitigated.
All faculty and planners for this activity have no relevant financial relationships with ineligible companies to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Certificates will be available for the participant to download.
Course Viewing Requirements
Supported Browsers:
Desktop: Newest and last prior version of Google Chrome, Firefox, Safari, and Microsoft Edge
Mobile devices: Newest and last prior version of Safari and Google Chrome
Supported Phones & Tablets:
All devices
Disclosures of Unlabeled Use
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), and the curriculum clearly indicates this fact.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected]